Author
Listed:
- Stewart Bates
(ABL Basic research Program)
- Andrew C. Phillips
(ABL Basic research Program)
- Paula A. Clark
(Imperial Cancer Research Fund Laboratories)
- Francesca Stott
(Imperial Cancer Research Fund Laboratories)
- Gordon Peters
(Imperial Cancer Research Fund Laboratories)
- Robert L. Ludwig
(National Cancer Institute, Frederick Cancer Research and Development Center)
- Karen H. Vousden
(National Cancer Institute, Frederick Cancer Research and Development Center)
Abstract
Most human cancers show perturbation of growth regulation mediated by the tumour-suppressor proteins retinoblastoma (RB) and p53 (ref. 1), indicating that loss of both pathways is necessary for tumour development. Loss of RB function leads to abnormal proliferation related to the deregulation of the E2F transcription factors, but also results in the activation of p53, which suppresses cell growth. Here we show that E2F-1 directly activates expression of the human tumour-suppressor protein p14ARF (the mouse homologue is called p19ARF), which binds to the MDM2-p53 complex and prevents p53 degradation2,5. These results complete a pathway linking abnormal proliferative signals, such as loss of RB, with the activation of a p53 response, through E2F-1 and p14ARF. They suggest that E2F-1, a protein inherently activated by cell-cycle progression, is part of a fail-safe mechanism to protect against aberrant cell growth.
Suggested Citation
Stewart Bates & Andrew C. Phillips & Paula A. Clark & Francesca Stott & Gordon Peters & Robert L. Ludwig & Karen H. Vousden, 1998.
"p14ARF links the tumour suppressors RB and p53,"
Nature, Nature, vol. 395(6698), pages 124-125, September.
Handle:
RePEc:nat:nature:v:395:y:1998:i:6698:d:10.1038_25867
DOI: 10.1038/25867
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:395:y:1998:i:6698:d:10.1038_25867. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.